US Patent 11905275 Bipyrazole derivatives as JAK inhibitors

US Patent 7598257 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors

US Patent 7834022 Metabolites of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

US Patent 8158616 Azetidine and cyclobutane derivatives as JAK inhibitors

US Patent 8410265 Processes for preparing JAK inhibitors and related intermediate compounds

US Patent 8415362 Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

US Patent 8486902 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

US Patent 8604043 3-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors

US Patent 8691807 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors

US Patent 8716303 N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

US Patent 8765734 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors

US Patent 8933085 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors

US Patent 8987443 Processes and intermediates for making a JAK inhibitor

US Patent 9034884 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors

US Patent 9181271 Tricyclic fused thiophene derivatives as JAK inhibitors

US Patent 9193733 Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors

US Patent 9249145 Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

US Patent 9359358 Cyclohexyl azetidine derivatives as JAK inhibitors

US Patent 9382231 Bipyrazole derivatives as JAK inhibitors

US Patent 9487521 Processes and intermediates for making a JAK inhibitor

US Patent 9498467 Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1

US Patent 9549916 Isoxazole hydroxamic acid compounds as LpxC inhibitors

US Patent 9926301 Bipyrazole derivatives as JAK inhibitors

US Patent 9926601 Alternatively spliced mRNA isoforms as prognostic indicators for metastatic cancer

US Patent 10435392 Bipyrazole derivatives as JAK inhibitors

US Patent 11001571 Bipyrazole derivatives as JAK inhibitors

US Patent 11591318 Bipyrazole derivatives as JAK inhibitors

C07D 403/14

A61P 37/06